A covariate-adjusted analysis was performed in order to identify socio-demographic and clinical factors related to the selection of best-worst items. The participants were asked to report any difficulties encountered during the survey. Results: A total of 143 patients, predominantly male (74%) and with a mean age of 58 years were enrolled in the survey. The strongest positive preference was expressed for a hospital-based program of physical examinations with frequency decreasing over time. Conversely, the lowest valued item was not performing any positron emission tomography (PET) scan during follow-up. Patients with high educational levels were more likely to value attending a primary care-based program and undergoing intensive radiological investigations. Other patient-specific variables significantly associated with the choice of items were employment and living status, time already spent in follow-up and number of treatments received. Conclusions: Overall, patients were more likely to choose an intensive follow-up scheme broadly consistent with the program currently administered by the hospital. There is little evidence of preference heterogeneity that might justify customized programs based on demographics. The best-worst scaling task appeared feasible for most participants.
Introduction
Head and neck cancer (HNC) is the sixth most common cancer in the world with nearly 700,000 new diagnoses and 370,000 deaths reported each year [1, 2] ; incidence in Italy has been assessed at 7.7 cases per 100,000 [3] . HNC consists of a heterogeneous group of malignancies affecting several anatomical sites and with different prognoses [4] . The main risk factors are alcohol and tobacco abuse and, in recent years, the infection with human papilloma virus for cancers located in the oropharynx [1] . The risk of relapse is greater in the first 2 years after primary treatment, when an estimated 50% to 60% of patients develop locoregional recurrences or metastases [1] ; lifetime risk of second primary cancers is around 10% to 20% (i.e., 2%-5% per year) [5] . Therefore, a follow-up program is essential shortly after the completion of treatment to identify potentially curable relapses. Nevertheless, the optimal timing of visits and radiological assessments after treatment is debated by oncologists. Published recommendations are mostly informed by retrospective studies, expert opinions, and clinical practice rather than by randomized controlled trialbased evidence [2, 5] . Until now, no consensus has been reached on the optimal follow-up modalities and timing in patients with HNC.
In addition to this clinical uncertainty, the patient's perspective has traditionally been neglected in designing cancer programs and elaborating clinical guidelines, although considering individual preferences might improve the feasibility, acceptability, and effectiveness of health care interventions [6] . This is part of a larger study evaluating the cost-effectiveness of different surveillance schemes in HNC (HETeCo, clinicaltrials.gov identifier NCT02262221). The present objective is to quantify preferences for post-treatment surveillance in a large sample of patients treated for primary HNC.
Methods
This study used best-worst scaling (BWS) to elicit patients' preferences for different aspects of follow-up after primary treatment for HNC.
Experimental Design
The best-worst (BW) choice experiment is a variant of the widely adopted binary choice experiment approach. As in traditional discrete choice experiments (DCEs), this method requires the identification of key characteristics (i.e., the attributes), each of which is split into two or more levels to create a series of scenarios described by different attribute-level combinations. Nevertheless, instead of selecting one scenario in a choice set of two or more, participants are asked to indicate which attribute-level they consider to be the "best" and which to be the "worst" (i.e., the BW pair) within each scenario. In other words, they choose "the pair that exhibits the largest perceptual difference on an underlying continuum of interest" [7, 8] . There exist three types of BWS studies in the literature: the object case (case 1), the profile or attribute case (case 2), and the multiprofile case (case 3) [9] . The present study used the profile case in which participants are presented with a series of different scenarios to be evaluated one at a time.
Our analysis was limited to the process-related aspects of the follow-up [10] , because clinical outcomes of post-treatment surveillance in HNC are still under debate in the scientific community. Relevant attributes and levels were established from literature review and expert opinion. We searched common databases (PubMed and EMBASE) using key terms such as "cancer" AND "follow up" AND "discrete choice experiment" (OR "best worst") in titles/abstracts to identify studies that assessed patients' preferences around post-treatment programs in oncology using stated preference methods. Interviews with six patients during routine hospital visits were used to refine terminology and evaluate the comprehension and the acceptability of the BWS instrument.
After this preliminary work, we eventually identified four attributes: frequency and setting (hospital or mixed with primary care) of physical investigations, frequency of radiological assessments (magnetic resonance imaging [MRI]/computed tomography [CT] scans), frequency (and eligibility) of positron emission tomography (PET) scans, and telephone calls to monitor the occurrence of new symptoms. Levels were presented in order of increasing intensity (and resources consumption) for each attribute (Table 1) . A balanced study design was adopted in which each study attribute (K ¼ 4) had the same number of levels (L K ¼ 3). If an alternative contains K attributes, there are K(K À 1) ¼ 4(4 À 1) ¼ 12 possible BW pairs the participant can choose within each scenario. Because a full factorial design generating all possible attribute-level combinations (3 4 ¼ 81 scenarios) was not feasible, a subset of 9 orthogonal scenarios (fractional factorial, main-effects design) was derived using the Hahn and Shapiro catalogue, Master Plan 3 [11] . The total number of BW pairs in the orthogonal design was 108 (12 Â 9) . This subgroup of selected scenarios preserved the properties of orthogonality (i.e., each attribute-level appears an equal number of times in combination with all other attribute-levels) and balance (i.e., each level within an attribute appears an equal number of times) [12, 13] .
Recruitment and Setting
Patients aged 18 years and older, with a diagnosis of HNC in any anatomical site (except for the skin) in the last 5 years, and who had completed any curative treatment at the National Cancer Institute (NCI) in Milan were eligible to participate. Patients were excluded if they were unable to comply with the study in the opinion of the clinical investigators, or if they could not provide their informed consent. Moreover, we excluded patients who underwent minor surgery for early stage cancer and subsequently did not attend a regular follow-up program in a multidisciplinary setting, that is, with the contemporary presence of the head and neck surgeon and the radiation and the medical oncologists. At the NCI, the routine follow-up program consists of outpatient visits every 2 to 3 months for the first 2 years after the end of treatment, then every 5 to 6 months for 3 more years. Radiological evaluations with MRI/CT scan are performed once 3 months after the end of treatment and then annually. PET is requested only in the case of doubtful imaging; no scheduled intervisit contact is planned during the follow-up period. The study was described to a consecutive sample of eligible patients during a routine follow-up appointment. Patients were reassured that responses to the questionnaire would not affect the care they were receiving at the hospital [14] . Those who agreed to participate were asked to sign a consent form and then they received the survey. Sociodemographic and clinical information was collected for each study participant. The questionnaire included a short rationale for the study and an explanation of the task required. The study was approved by the NCI Ethical Committee in March 2015; the survey was subsequently administered between May and October of the same year.
Statistical Analysis
Data on patients' characteristics were summarized through descriptive statistics; categorical variables were presented as percentages, whereas continuous variables were presented as means and standard deviations (SDs). In regression analyses, missing demographic data were imputed using logical rules and information from related variables or, whenever this approach was not feasible, using the most common value (i.e., the mode) [15] . Missing BW responses were imputed with the items most frequently selected as best and worst, respectively, within each scenario. The number of times each item was chosen as best or worst by the study participants was calculated. A best-minusworst score was calculated by subtracting the number of times a feature was chosen as worst from the number of times it was chosen as best [6, 14] .
Regression analysis was performed using a conditional logit model (clogit command in Stata) with cluster-adjusted (robust) standard errors [16] . BW pairs were treated as single variables and plotted as one data point at the individual level [17] . For each possible pair, the attribute-level was coded as 1 for the best and -1 for the worst; all remaining attribute-levels were coded as 0. The dependent variable took the value of 1 for the BW pair selected and 0 otherwise. To avoid a saturated model, the item that showed the lowest utility was used as reference level; the omitted item took the value of 0 on the utility scale and all estimates of the model were interpreted in relation to that. Therefore, each attribute-level can be positioned on an underlying preference scale (0; þ1), starting with the reference item [9, 18] . Statistically significant coefficients indicated the importance of the attribute-level in determining overall utility [19] .
A covariate-adjusted analysis was also performed to investigate subgroup preferences according to sociodemographic and clinical characteristics. A conditional logit model was run as previously described; nevertheless, interaction factors between selected covariates and choice outcomes (i.e., attribute-levels) were also added as independent variables [16] . In this model, interaction coefficients represent the additional utility of each attribute-level for the covariate [6] . A preliminary univariate regression analysis was performed to identify the demographic variables to be included in the final covariate-adjusted model as those displaying significant interaction terms (P o 0.05). Variables with three (or more) categories in the questionnaire were dichotomized to increase the sample size within each group. Two age classes were generated around its median value (59 years) [6] . With regard to the clinical variables, the number of treatments received (i.e., one vs. more than one) was chosen as a "proxy" of disease severity that, according to the clinicians involved in the study, might influence patients' preferences in follow-up; the time from the end of treatments was equally considered clinically relevant. Any other clinical information was disregarded in this analysis.
All data were analyzed using Stata version 14 (StataCorp, College Station, TX).
Results

Sample Characteristics
A total of 162 consecutive patients who met the inclusion criteria were approached to participate in the survey; nevertheless, 16 declined, resulting in a response rate of 90%. Three questionnaires were excluded from data analysis because they were not completed correctly or in full. Therefore, the final sample comprised 143 patients, of whom 74% were males. Sociodemographic and clinical features of the participants are presented in Table 2 . The mean age of participants was 57.6 Ϯ 12.1 years and more than one-third of patients were retired (34.2%). Most of the patients (85.3%) lived with family and 64.3% lived less than 100 km from the hospital.
Various primary tumor diagnoses were observed in the sample, with the most common being oropharyngeal (38.4%), nasopharyngeal (28.0%), and laryngeal (11.2%) cancer, mostly in a locally advanced stage (III and IV; 93.7%). Most patients (38.5%) received a combination of chemotherapy and radiation as primary treatment for HNC, or chemotherapy followed by a combination of chemotherapy and radiation (30.0%). Participants were equally distributed according to time since the end of treatments: 2 years or less, 51.0%; more than 2 years, 49.0%.
BWS Frequency Counts
Frequency counts provide summary estimates of BW choices made by participants (Table 3) . Of a total of 2574 expected BW responses, only 12 (0.5%) were missing and imputed as previously explained. The highest ranked attribute-level was "physical investigations performed every 2-3 months for 2 years, then every 5-6 months for 3 more years." The lowest rated feature is less clearly identifiable. According to the bestminus-worst score, the lowest valued attribute-level was "intervisit calls by the nurse" to monitor patients' health status. "No PET scan during follow-up" was the item least frequently chosen as "best," whereas "primary care-based follow-up during the last 2 years" was the item most often indicated as "worst."
Conditional Logistic Regression Analysis
The logistic regression results are presented in Table 4 . The attribute-level with the lowest utility coefficient was "not performing any PET scan during follow-up" and was assumed as the reference level. The regression coefficients of BW pairs show the additional utility of each attribute-level over the reference case. As already observed in frequency counts, the feature showing the highest utility was "physical investigations performed every 2-3 months for 2 years and every 5-6 months for 3 more years." A more intensive frequency of visits, "every 2-3 months for 5 years," ranked second, and "MRI/CT scan performed once or twice a year" ranked third. In contrast, the attribute-levels with the lowest utility were "follow-up based at primary care during the last 2 years," "intervisit calls by the nurse," and "no intervisit calls from the hospital," in that order; none of them was, however, statistically significant compared with the reference level.
For each individual attribute, the distance between the most and the least preferred levels is an indication of the relative importance of that attribute to respondents [9, 18] . In this survey, the "frequency and setting of physical (and larynx/ pharynx endoscopic) investigations" is the item with the largest difference between level coefficients (2.482, i.e., 2.523 À 0.041) and, thus, the greatest impact on patients' utilities. Summing the level coefficients taken one at a time within each attribute, it is possible to calculate an overall utility for each hypothetical follow-up scheme deriving from the experiment. The most preferred scenario (overall utility 6.120) across the sample would be a hospital-based follow-up with frequency of visits decreasing over time (i.e., every 2-3 months for 2 years, every 5-6 months for the next 3 years), radiological assessments (i.e., MRI/CT) performed once or twice a year, yearly PET scan for all patients (irrespective of individual risk of recurrences), and intervisit calls by the oncologist to monitor the occurrence of new symptoms. On the contrary, the least desirable option is a mixed hospital-based/primary care-based surveillance with MRI/CT scan performed only at the occurrence of new symptoms, no PET scan scheduled during the follow-up period, and intervisit calls by the nurse to check the patient's health (scenario utility 0.654). Table 5 presents results from the conditional logistic regression analysis after adjusting for selected clinical and demographic data. Education level (more educated, i.e., university, postuniversity ¼ 1; less educated, i.e., primary school, secondary school ¼ 0), 0 1 7 ) 7 9 9 -8 0 8 employment status (employed, i.e., full-time employed, part-time employed, self-employed ¼ 1; not employed, i.e., retired, unemployed, other ¼ 0), living status (with family ¼ 1; alone ¼ 0), time in follow-up (42 years ¼ 1; r2 years ¼ 0), and number of treatments (Z1, i.e., 2, 3, or 4 ¼ 1; 1 only ¼ 0), which displayed significant interactions in univariate regression analysis (see Appendix Tables S1-S8 in Supplemental Materials found at http://dx.doi.org/10.1016/j. jval.2017.01.012), were included in the final model. Conversely, no significant interaction coefficients were found with respect to age (age Z 59 years ¼ 1; age o 59 years ¼ 0), sex (female ¼ 1; male ¼ 0), and distance from home (Z100 km ¼ 1; o100 km ¼ 0).
Covariate-Adjusted Regression Analysis
The interpretation of regression results is facilitated through the example of education. There were statistically significant differences between education groups with respect to three of the four attributes in the experiment. The total utility of "MRI/CT scan performed once or twice a year" for highly educated patients is the sum of the attribute-level coefficient (1.590) and its interaction term coefficient with education level (0.756), which gives 2.346. The corresponding CT, chemotherapy; CTRT, combined chemoradiotherapy; HPV, human papilloma virus; RT, radiotherapy.
utility for less educated people is the coefficient without interaction (1.590). Thus, we can infer that all patients like a more intensive radiological investigations program; this preference is, however, stronger for those who are more educated. Furthermore, more highly educated patients are more likely to prefer a primary carebased follow-up than patients with a lower education level. The total utility of this item, indeed, is equal to 1.878 for the former, whereas not significantly different from the reference value for the latter (0.178). The last significant interaction is with "no PET scan during follow-up"; the overall utility for the more educated patients is 0.201, whereas not significantly different from 0 for the less educated ones. In a similar way, it is possible to calculate separate utilities for different groups of patients according to the remaining four relevant covariates. Table 6 presents data on patients' self-reported difficulties in understanding and completing the questionnaire. The average compilation time was 9.2 Ϯ 3.1 minutes. Nearly half the participants rated the BWS task as very easy to perform (i.e., level 1; 45.4%) and they did not need any support from health care professionals or family members (44.7%). More than onethird (37.1%) reported no difficulties during completion among the options available; "understanding the task" was the most common difficulty (21.7%) followed by "length of the questionnaire" (6.3%) and "technical/scientific language" (5.6%). A further 14% indicated other difficulties mainly related to indecision in selecting the BW pair and the feeling that scenarios were too repetitive. V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 7 9 9 -8 0 8 0 1 7 ) 7 9 9 -8 0 8
Patients' Evaluation of the Experiment
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Discussion
Few studies have explored patients' preferences for delivery of post-treatment cancer programs and even fewer have attempted to derive utility estimates from them. A nonsystematic literature review identified two binary DCE studies [20, 21] exploring women's preferences for breast cancer follow-up services in the Netherlands and Australia, respectively. Face-to-face contacts were strongly preferred to telephonic ones and a more intensive program of visits (every 3-6 months) was preferred over less intensive options. Moreover, women liked to be followed up by a V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 7 9 9 -8 0 8
medical specialist and at specialized breast cancer clinics. A BWS study of post-treatment surveillance for soft tissue sarcoma in the United Kingdom concluded that patients typically preferred visits routinely consisting of a clinical examination and a chest x-ray, and secondary care-based rather than general practicebased programs [17] . A further study [6] adopting the BWS methodology was identified even if not strictly related to follow-up but addressing a symptom supporting care intervention in patients with lung cancer after completion of first-line therapies. With respect to HNC, a non-DCE survey only on patients' perspective of their follow-up regimen was conducted in the United Kingdom. The study revealed that most patients felt their follow-up visits to be too frequent and were in favor of a less-intensive, symptom-driven follow-up [22] . The BWS method is argued to have several advantages over traditional DCEs [6, 18] . First, respondents are provided with profiles one by one rather than two (or more) at a time; thus, BWS is considered less cognitively demanding for participants [8, 16, 19, 23] . These expectations were confirmed in our study by the self-reported judgment on the choice task, which was graded as simple and quick by most of the respondents. Moreover, BWS may elicit more information than traditional DCEs, because respondents make choices within profiles rather than between profiles; in particular, in BWS a single attribute-level combination acts as a benchmark, instead of a whole scenario. In this way, it is possible to calculate utility coefficients for each item in the experiment, which may be useful in evaluating different elements of a health care service [8, 16, 19, 23] . Profile-based BWS was selected in preference to the traditional pairwise DCE because it was anticipated that patients would always select the option that they thought would maximize survival and consequently less information would be generated by responses to the pairwise choice task.
This study is the first stated preference survey of HNC followup and, in Italy, of any cancer surveillance. The survey aimed at providing insights into patients' views on post-treatment monitoring in this cancer population using the BWS methodology. Moreover, a covariate-adjusted analysis was performed to find sociodemographic or clinical characteristics related to the choice of attribute-levels. It was not surprising to find that patients' preferences for HNC follow-up were generally aligned with the scheme currently adopted by the NCI where the study was conducted. This tendency has been described as the "lure of the familiar" [17] , meaning that individuals are likely to stick with what they have already experienced, even if potentially unsatisfactory. Participants in this study revealed clear preferences for follow-up to remain in secondary care, even during the last phases of the program. Intensive radiological examinations (once or twice a year) were strongly preferred. Intervisit telephone calls were generally disliked, especially when performed by health care professionals other than medical doctors. These results are in contrast with those found by a previous study on patients' preferences in HNC follow-up [22] ; that survey was, however, conducted in a different geographical setting (highly deprived areas of London) and without relying on stated preference methods. Differences in preferences according to individual characteristics were also found. Overall, highly educated patients were more likely to prefer primary care-based follow-up and intensive MRI/CT radiological investigations but avoid PET scan. Patients with a job tended to prefer more frequent visits to the hospital but no intervisit calls, whereas those living with family revealed a stronger preference for not performing any PET scan during follow-up. Patients following treatment for 2 years (or more) expressed a lower utility for more intensive MRI/CT investigations and were keener to avoid intervisit telephone calls with their clinicians. Patients who had received more than one treatment option (e.g., surgery followed by radiotherapy) were less keen to accept a symptom-driven radiological surveillance and to travel frequently to the hospital for physical investigations. In contrast to a previous study [6] , we found no differences in age or sex with regard to preferences for delivering a posttreatment intervention in cancer care; nevertheless, the program under evaluation was considerably different.
This study has a number of limitations. First, the data collection was restricted to only one center, which, because of some distinctive features (e.g., high specialization, commitment BWS, best-worst scaling.
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to research, and cutting-edge technologies), may not be representative of a typical cancer clinic in Italy. Moreover, patients attending the NCI, especially those coming from far, are likely to be more educated, wealthy, or health-conscious than the general HNC population. Nevertheless, the referral to a single center reduced bias related to different ways of administering the survey and providing support during the completion of the questionnaire. Second, the cognitive ability of each participant with respect to completing the task was not evaluated and on some occasions the patient was supported by the accompanying person. Nevertheless, given the very low number (n ¼ 3) of questionnaires excluded from the analysis and the limited selfreported difficulties, we are confident that the task was feasible for most participants. The final limitations concern the restricted range of hypothetical follow-up programs that can be valued because of the small number of attribute-levels and the assumption of no interaction between BWS items. Nevertheless, the limited number of items included in the experiment, as well as the use of a small factorial main-effects design (i.e., 9 out of 81 scenarios), was justified by feasibility considerations. In recent years, there has been growing interest in using preference elicitation methods to inform health policy and medical decision making. Incorporating patients' preferences into the treatment and follow-up strategies may help in tailoring health care to the patient and increase adherence to treatment [24] . In HNC follow-up, patients seem to be reassured by a regular follow-up with scheduled imaging and expertise of specialists, as already reported in other experiences [25] . The present study highlighted the limited interest of patients with HNC in alternative ways of delivering post-treatment services, such as symptom-driven surveillance, telephone monitoring, or nonspecialist follow-up. Health care professionals other than specialist doctors (e.g., general practitioners or nurses) were probably considered not skilled enough to conduct cancer follow-up. There may be a resistance to change from established to new types of service without adequate reassurance from the clinicians. In particular, patients with less education may benefit least from a patient-initiated follow-up because of difficulties in understanding medical instructions. Overall, there is a need for improved communication for patients with cancer to evaluate consciously the post-treatment phase and to promote self-managed symptoms monitoring [26] . Patients most likely prefer intensive radiological assessment because of fear of disease recurrence. Tests should, however, be performed for clinical reasons and not (only) for patients' reassurance. The long-term effects associated with frequent and prolonged radiological scans should also be considered. In this regard, more efforts should be made to identify the most cost-effective follow-up scheme in HNC, thus providing the scientific community and patients with evidence-based programs. A randomized trial comparing health and economic outcomes in this setting is ongoing (HETeCo, clinicaltrials.gov identifier NCT02262221). Finally, differences in preferences were found according to the intensity of treatments received and the time already spent in follow-up; these results might justify provision of different surveillance schemes on the basis of these clinical variables, as already suggested by guidelines in the field [27] . Similarly, intervisit calls appear to be more valuable in the initial phases of the follow-up than in the final ones, when patients may feel more confident of beating cancer.
Overall, this study provided useful insights into individual preferences for several aspects of post-treatment surveillance in HNC in Italy. Additional elements might be explored in the future, such as the level of scientific evidence, co-payment for extra investigations, and late side effects of intensive investigations. Currently, there is evidence of heterogeneity in preferences with respect to a limited number of patient characteristics. More research also considering the costs of different follow-up regimens is required to justify the provision of customized follow-up programs in patients with HNC.
